Uncertainty analysis of MR-PET image registration for precision neuro-PET imaging.


Journal

NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515

Informations de publication

Date de publication:
15 05 2021
Historique:
received: 10 09 2020
revised: 25 12 2020
accepted: 21 01 2021
pubmed: 16 2 2021
medline: 15 10 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Accurate regional brain quantitative PET measurements, particularly when using partial volume correction, rely on robust image registration between PET and MR images. We argue here that the precision, and hence the uncertainty, of MR-PET image registration is mainly driven by the registration implementation and the quality of PET images due to their lower resolution and higher noise compared to the structural MR images. We propose a dedicated uncertainty analysis for quantifying the precision of MR-PET registration, centred around the bootstrap resampling of PET list-mode events to generate multiple PET image realisations with different noise (count) levels. The effects of PET image reconstruction parameters, such as the use of attenuation and scatter corrections and different number of iterations, on the precision and accuracy of MR-PET registration were investigated. In addition, the performance of four software packages with their default settings for rigid inter-modality image registration were considered: NiftyReg, Vinci, FSL and SPM. Four distinct PET image distributions made of two early time frames (similar to cortical FDG) and two late frames using two amyloid PET dynamic acquisitions of one amyloid positive and one amyloid negative participants were investigated. For the investigated four PET frames, the biggest impact on the uncertainty was observed between registration software packages (up to 10-fold difference in precision) followed by the reconstruction parameters. On average, the lowest uncertainty for different PET frames and brain regions was observed with SPM and two iterations of fully quantitative image reconstruction. The observed uncertainty for the varying PET count-level (from 5% to 60%) was slightly lower than for the reconstruction parameters. We also observed that the registration uncertainty in quantitative PET analysis depends on amyloid status of the considered PET frames, with increased uncertainty (up to three times) when using post-reconstruction partial volume correction. This analysis is applicable for PET data obtained from either PET/MR or PET/CT scanners.

Identifiants

pubmed: 33588030
pii: S1053-8119(21)00098-7
doi: 10.1016/j.neuroimage.2021.117821
pmc: PMC8204268
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

117821

Subventions

Organisme : Wellcome Trust
ID : 203147/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N013042/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 203148/Z/16/Z
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N025792/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Références

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):613-20
pubmed: 22270508
Phys Med Biol. 1994 May;39(5):847-71
pubmed: 15552089
IEEE Trans Med Imaging. 2010 Jul;29(7):1442-54
pubmed: 20409989
IEEE Trans Med Imaging. 2000 May;19(5):493-506
pubmed: 11021692
Phys Med Biol. 1994 May;39(5):833-46
pubmed: 15552088
Phys Med Biol. 2002 May 21;47(10):1761-75
pubmed: 12069092
J Nucl Med. 2018 Oct;59(10):1583-1589
pubmed: 29674420
Neuroimage Clin. 2018 Apr 04;19:182-189
pubmed: 30023168
J Nucl Med. 2002 Dec;43(12):1715-26
pubmed: 12468524
IEEE Trans Med Imaging. 2015 Sep;34(9):1976-88
pubmed: 25879909
J Nucl Med. 2016 Feb;57(2):198-203
pubmed: 26541776
IEEE Trans Image Process. 1996;5(3):493-506
pubmed: 18285134
Phys Med Biol. 2015 Jan 7;60(1):279-99
pubmed: 25490178
Neuroimage. 2017 Feb 15;147:669-677
pubmed: 28039094
BMC Neurol. 2017 Apr 18;17(1):75
pubmed: 28420323
Annu Rev Biomed Eng. 2019 Jun 4;21:551-581
pubmed: 31167104
Brain Imaging Behav. 2021 Feb;15(1):190-204
pubmed: 32125613
Hum Brain Mapp. 2017 Jul;38(7):3323-3336
pubmed: 28432784
Phys Med Biol. 2016 Jul 7;61(13):N322-36
pubmed: 27280456
Neuroimage. 2009 Oct 1;47(4):1496-505
pubmed: 19481154
J Nucl Med. 2018 Nov;59(11):1761-1767
pubmed: 29653974
BMC Med Imaging. 2015 Aug 12;15:29
pubmed: 26263899
Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1447-58
pubmed: 26105119
Phys Med Biol. 2018 Jan 26;63(3):035014
pubmed: 29192605
Phys Med Biol. 2012 Nov 7;57(21):R119-59
pubmed: 23073343
Eur J Nucl Med Mol Imaging. 2011 Jun;38(6):1104-19
pubmed: 21336694
J Med Imaging (Bellingham). 2014 Jul;1(2):024003
pubmed: 26158035
IEEE Trans Med Imaging. 1994;13(4):601-9
pubmed: 18218538
Neuroinformatics. 2018 Jan;16(1):95-115
pubmed: 29280050
Semin Nucl Med. 2012 May;42(3):208-18
pubmed: 22475429
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2144-9
pubmed: 25002030
Imaging Med. 2010 Oct 1;2(5):529-545
pubmed: 21339831
Neuroimage. 2015 Mar;108:450-9
pubmed: 25482269
Phys Med Biol. 2012 Nov 7;57(21):6779-95
pubmed: 23032513

Auteurs

Pawel J Markiewicz (PJ)

Centre for Medical Image Computing; Department of Medical Physics and Biomedical Engineering, University College London Gower Street WC1E 6BT, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, UK. Electronic address: http://www.nmi.cs.ucl.ac.uk.

Julian C Matthews (JC)

Division of Neuroscience & Experimental Psychology, University of Manchester, UK.

John Ashburner (J)

Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, University College London, UK.

David M Cash (DM)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, UK.

David L Thomas (DL)

Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, University College London, UK; Dementia Research Centre, Queen Square Institute of Neurology, University College London, UK.

Enrico De Vita (E)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK.

Anna Barnes (A)

Institute of Nuclear Medicine, University College London, London, UK.

M Jorge Cardoso (MJ)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK.

Marc Modat (M)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK.

Richard Brown (R)

Institute of Nuclear Medicine, University College London, London, UK.

Kris Thielemans (K)

Institute of Nuclear Medicine, University College London, London, UK.

Casper da Costa-Luis (C)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK; Centre for Medical Image Computing; Department of Medical Physics and Biomedical Engineering, University College London Gower Street WC1E 6BT, London, UK.

Isadora Lopes Alves (I)

Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Amsterdam, Netherlands.

Juan Domingo Gispert (JD)

Barcelonaßeta Brain Research Center (BBRC), Pasqual Maragall Foundation, Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Madrid, Spain.

Mark E Schmidt (ME)

Janssen Pharmaceutica NV, Beerse, Belgium.

Paul Marsden (P)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK.

Alexander Hammers (A)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK.

Sebastien Ourselin (S)

School of Biomedical Engineering and Imaging Sciences, King's College London, UK.

Frederik Barkhof (F)

Centre for Medical Image Computing; Department of Medical Physics and Biomedical Engineering, University College London Gower Street WC1E 6BT, London, UK; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Radiology and Nuclear Medicine, Amsterdam, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH